DERL1 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP8745B
Article Name: DERL1 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8745B
Supplier Catalog Number: BP8745b
Alternative Catalog Number: ABT-BP8745B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Derlin-1, Degradation in endoplasmic reticulum protein 1, DERtrin-1, Der1-like protein 1, DERL1, DER1
Functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal proteins. DERL1 may act by forming a channel that allows the retrotranslocation of misfolded proteins into the cytosol where they are ubiquitinated and degraded by the proteasome. It may mediate the interaction between VCP and the degradation substrate. In case of infection by cytomegaloviruses, it plays a central role in the export from the ER and subsequent degradation of MHC class I heavy chains via its interaction with US11 viral protein, which recognizes and associates with MHC class I heavy chains. Also participates in the degradation process of misfolded cytomegalovirus US2 protein.
NCBI: 79139
UniProt: Q9BUN8
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8745b was selected from the C-term region of human DERL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.